Trends in Genetics
The VHL tumour-suppressor gene paradigm
Section snippets
The VHL gene and VHL disease
The 213 amino acid coding sequence of the VHL gene is represented in three exons contained within a 20 kb region at chromosome 3p25 (Ref. [3]). Germline mutations cause VHL disease (Fig. 1), a dominantly inherited disorder characterized by variable expression and susceptibility to a variety of malignant and benign tumours[4]. The VHL TSG mRNA is expressed widely during embryogenesis and in adult tissues5, 6. In particular, tissue-specific differences in VHL mRNA or protein (pVHL) production do
The VHL TSG and sporadic cancers
As for inherited retinoblastoma, tumours from VHL patients characteristically demonstrate loss of the wild-type allele, consistent with the classical two-hit model of tumourigenesis[14]. RCC accounts for about 2% of all cancers and the most common subtype is described as `clear cell' according to the microscopic appearance of the tumour cells. VHL disease accounts for less than 2% of all cases of kidney cancer, but somatic VHL gene mutations are found in most nonfamilial RCC15, 16. This is
pVHL regulates angiogenesis
Angiogenesis is critical for normal development and for tumourigenesis. VHL-associated neoplasms, such as haemangioblastoma and RCC, are notable for their vascularity [retinal haemangioblastomas are sometimes referred to as angiomas (Fig. 2)]. These tumours produce high levels of vascular endothelial growth factor (VEGF). Although overproduction of VEGF mRNA is a feature of many human cancers, this has been primarily linked to hypoxia. However, RCCs lacking functional pVHL produce high levels
The VHL protein product
The full-length 213 amino acid VHL protein (VHLL) migrates with an apparent molecular weight of ∼28–30 kDa, but a second form of VHL protein (VHLS), generated by translation initiation at an internal methionine located at residue 54, migrates with an apparent molecular weight of 19 kDa. The primary sequence of pVHL is not highly similar to that of any known protein and did not provide any clues to the possible function. To elucidate possible functions, several groups sought to identify
The VHL TSG: an evolving paradigm
This review has highlighted some of the similarities between the retinoblastoma TSG paradigm and VHL disease. In both cases, the characterization of a gene accounting for a rare familial cancer syndrome has led to the identification of a critical gatekeeper gene that is frequently mutated in more common sporadic cancers. RB1 and VHL function as recessive TSGs and, at the time of their identification, the possible biochemical functions of the RB1 and VHL protein products were unknown. The
Acknowledgements
We apologize to those investigators whose work we were unable to cite because of lack of space. We thank Farida Latif, and members of the Kaelin and Maher Labs for helpful suggestions and criticisms. Hartmut Neumann provided part of Fig. 1.
References (47)
- et al.
Hum. Pathol.
(1997) Eur. J. Cancer
(1995)- et al.
Cell
(1996) J. Biol. Chem.
(1996)- et al.
Trends Genet.
(1998) Cell
(1992)- et al.
Biochim. Biophys. Acta
(1994) - et al.
Cell
(1990) Science
(1997)Proc. Natl. Acad. Sci. U. S. A.
(1971)
Science
Medicine
Hum. Mol. Genet.
Q. J. Med.
Hum. Genet.
Hum. Mutat.
Hum. Mol. Genet.
Hum. Mutat.
J. Am. Med. Assoc.
Hum. Genet.
Hum. Mol. Genet.
Nat. Genet.
Cited by (203)
Discoveries of how cells sense oxygen win the 2019 Nobel Prize in Physiology or medicine
2020, Biomedical JournalUnderstanding the Oxygen-Sensing Pathway and Its Therapeutic Implications in Diseases
2020, American Journal of PathologyHemangioblastomas of the central nervous system
2020, Rosenberg’s Molecular and Genetic Basis of Neurological and Psychiatric Disease: Volume 2Expression of Ring Box-1 protein and its relationship with Fuhrman grade and other clinical-pathological parameters in renal cell cancer
2020, Urologic Oncology: Seminars and Original InvestigationsNickel impact on human health: An intrinsic disorder perspective
2016, Biochimica et Biophysica Acta - Proteins and Proteomics